NCT01991457View on ClinicalTrials.gov

Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 27, 2013

Primary Completion Date

January 30, 2020

Study Completion Date

August 23, 2022

Conditions
Adult Lymphoblastic Lymphoma
Interventions
DRUG

Fludarabine

PROCEDURE

Total Body Irradiation

Trial Locations (1)

35249

UAB Bone Marrow Transplantation and Cellular Therapy Program, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT01991457 - Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter